Press Release · Press Releases
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
NEREUS™ significantly reduced semaglutide induced vomiting including frequent multi-day and extreme vomiting Key Results Any vomiting (primary) 43.0% (61/142) vs 58.5% (96/164) placebo (p=0.006); 27% relative reduction Vomiting + severe nausea (key secondary): 33.1% (47/142) vs 50.6%...
This press release summary is reproduced from the issuer's public feed.
Read the full release at PR NewswireOriginal publisher: PR Newswire
Spotted an error? Request a correction · Corrections Policy
Related stories
DNB Launches new fund focusing on Europe's energy security
OSLO, Norway, Oct. 27, 2026 /PRNewswire/ -- Europe is facing a historic wave of investments in energy and critical infrastructure. DNB is now launching DNB Fund European Energy Security, a new mutual fund designed to invest in companies helping secure Europe's future energy supply....
PR Newswire ·
Bitmine Immersion Technologies (BMNR) maakt bekend dat zijn ETH-bezit 6,05 miljoen tokens bedraagt en dat de totale waarde van zijn cryptobezittingen, liquide middelen en verhandelbare effecten 15 miljard dollar bedraagt
Bitmine heeft de afgelopen week 2,04 miljoen aandelen teruggekocht Bitmine heeft tot nu toe in 2026 in totaal 22,9 miljoen aandelen teruggekocht, de grootste aandeleninkoop ooit uitgevoerd door een crypto-treasurybedrijf. Bitmine bezit 4,95% van het totale aanbod van ETH-munten van 122,2...
PR Newswire ·
Infosys accompagne Syngenta dans sa transformation mondiale vers SAP S/4HANA
Cette nouvelle infrastructure numérique unifiée simplifie les opérations de plus de 10 000 collaborateurs dans 80 pays et pose les bases des innovations futures du Groupe. BENGALURU, India, 27 octobre 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY) , leader mondial du...
PR Newswire ·
Posterity Health Accelerates National Expansion with New Reproductive Urology Partnerships Across Six Markets
DENVER, Oct. 27, 2026 /PRNewswire/ -- Posterity Health, the nation's leading physician-led male fertility platform, today announced the expansion of its national reproductive urology network into five new markets: Orange County, California; Dallas, Texas; Las Vegas, Nevada; Chicago,...
PR Newswire ·
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
CDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026 Study Demonstrated 97.3% Sensitivity and 96.0% Specificity Consistent Performance Across Three Test Batches Integrated Mobile and Cloud Infrastructure Already Deployed in India to Support Anticipated...
PR Newswire ·
Commvault Announces Second Quarter Fiscal 2027 Financial Results
Subscription revenue1 climbs +21% year over year to $269 million Subscription annualized recurring revenue (ARR)1,2 reaches $1,104 million, up +20% year over year Operating cash flow of $75 million, with free cash flow3 of $71 million TINTON FALLS, N.J. , Oct. 27, 2026 /PRNewswire/ --...
PR Newswire ·